GSWM
FLGT icon

Golden State Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Golden State Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$1.69K – 1599
2025
Q1 		$1.69K Hold
100
– – ﹤0.01% 1345
2024
Q4 		$1.85K Buy
+100
New +$1.95K ﹤0.01% 1265

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Golden State Wealth Management's FLGT Position: Q2 2025 in Review

Golden State Wealth Management sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 100 shares — an estimated $1.69K sold.

Golden State Wealth Management first reported a position in FLGT in Q4 2024 and held it in 2 quarters. The position peaked at $1.85K in Q4 2024. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Golden State Wealth Management reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Golden State Wealth Management sold 100 Fulgent Genetics shares in Q2 2025, an estimated $1.69K.
  • Golden State Wealth Management first reported a position in Fulgent Genetics in Q4 2024 and held it in 2 quarters.
  • Golden State Wealth Management's Fulgent Genetics position peaked at $1.85K in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Golden State Wealth Management's 13F filing for Q2 2025, filed 6 Aug 2025.